Evidence map›Paper›PMID 30679931›Full record

ArticleNew genetics and society2018

"I6 passages: on the reproduction of a human embryonic stem cell line from Israel to France".

Noémie Merleau-Ponty, Sigrid Vertommen, Michel Pucéat

Abstract read
In one paragraph

Article in New genetics and society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Noémie Merleau-PontyDepartment of Sociology, University of Cambridge, Cambridge, UK.
Sigrid VertommenDepartment of Global Health & Social Medicine, King's College London, London, UK.
Michel PucéatInstitut National de la Santé Et de la Recherche Médicale U1251, Aix-Marseille University, Medical School La Timone, Marseille, France.

Funding

Wellcome Trust 209829/Z/17/Z
6 · The paper itself

Abstract

The first French clinical trial using human embryonic stem cells for regenerative purposes was launched in 2014, using the I6 stem cell line that was imported from Israel. From Israel to France, national reproductive policies and practices inform how basic scientists produce, manage and circulate cells across countries. Building on an interdisciplinary co-production involving two social scientists and a life scientist, this article suggests that biobanks

Indexed as

biobankFranceIsraelpassagereproductionstem cells

Identifiers

PMID30679931
PMCPMC6319182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.